1. Inicio
  2. Publicaciones
  3. Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

Fecha de publicación:

Autores de CIPF

Participantes ajenos a CIPF

  • Frasquet, M
  • Pelayo-Negro, AL
  • Garcia-Sobrino, T
  • Sedano, MJ
  • Pardo, J
  • Misiego, M
  • Garcia-Garcia, J
  • Sobrido, MJ
  • Chumillas, MJ
  • Vilchez, JJ
  • Vazquez-Costa, JF
  • Sevilla, T

Grupos de Investigación

Abstract

Background Mutations in the metalloendopeptidase (MME) gene were initially identified as a cause of autosomal recessive Charcot-Marie-Tooth disease type 2 (CMT2). Subsequently, variants in MME were linked to other late-onset autosomal dominant polyneuropathies. Thus, our goal was to define the phenotype and mode of inheritance of patients carrying changes in MME. Methods We screened 197 index cases with a hereditary neuropathy of the CMT type or distal hereditary motor neuropathy (dHMN) and 10 probands with familial amyotrophic lateral sclerosis (fALS) using a custom panel of 119 genes. In addition to the index case subjects, we also studied other clinically and/or genetically affected and unaffected family members. Results We found 17 variants in MME in a total of 20 index cases, with biallelic MME mutations detected in 13 cases from nine families (three in homozygosis and six in compound heterozygosis) and heterozygous variants found in 11 families. All patients with biallelic variants had a similar phenotype, consistent with late-onset axonal neuropathy. Conversely, the phenotype of patients carrying heterozygous mutations was highly variable [CMT type 1 (CMT1), CMT2, dHMN and fALS] and mutations did not segregate with the disease. Conclusion MME mutations that segregate in an autosomal recessive pattern are associated with a late-onset CMT2 phenotype, yet we could not demonstrate that MME variants in heterozygosis cause neuropathy. Our data highlight the importance of establishing an accurate genetic diagnosis in patients carrying MME mutations, especially with a view to genetic counselling.

Datos de la publicación

ISSN/ISSNe:
0022-2593, 1468-6244

JOURNAL OF MEDICAL GENETICS  BMJ PUBLISHING GROUP

Tipo:
Article
Páginas:
814-823
PubMed:
30415211

Citas Recibidas en Web of Science: 20

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • clinical genetics; peripheral nerve disease; neuromuscular disease; diagnostics; genetic screening/counselling

Campos de Estudio

Proyectos asociados

An integrative approach to develop cellular models and characterize disease mechanisms implicated in CMT2Z, a newly described axonal form of neuropathy

Investigador Principal: CARMEN ESPINÓS ARMERO

ASSOCIATION FRANÇAISE CONTRE LES MYOPATHIES . 2018

Biomarcadores para oncología de precisión en cáncer de Pulmón, Colorrectal y Melanoma

Investigador Principal: CARMEN ESPINÓS ARMERO

AGENCIA VALENCIANA DE INNOVACIÓN . 2018

Avanzar en el diagnóstico, la prognosis y la terapia de enfermedades neurodegenerativas raras

Investigador Principal: CARMEN ESPINÓS ARMERO

INSTITUTO DE SALUD CARLOS III . 2016

De genes a terapia en enfermedades neurodegenerativas y neuromusculares. Concedido a la UV

Investigador Principal: CARMEN ESPINÓS ARMERO

CONSELLERIA DE EDUCACION . 2018

Compartir